Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

A new pill for the most common type of advanced breast cancer has been approved for use on the NHS. Up to 3,000 women every year could benefit from the twice a day pill capivasertib, for hormone ...

A twice-daily pill has been approved for use on the NHS ... could benefit up to 3,000 women a year living with the most common type of advanced breast cancer. Article continues below Scientists ...

We’re trying to understand that right now, we are not aspirational; we’re Indian in the way we think, and the common man wants stories about us. "So, the people we’re surrounded by are ...

A TWICE-a-day pill which slows or stops the most common type of advanced breast cancer has been approved for use on the NHS. Scientists say it is a “landmark moment” as up to 3,000 women a ...

A new drug has been approved on the NHS for advanced breast cancer (Alamy/PA) A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists ...

A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”. Around 1,100 – and potentially up to 3,000 – women ...